GC Biopharma Corp.(KR:006280)
₩134,000.00-6000.00 (-4.29%)
KR:006280
GC Biopharma Corp. financials statements
₩134,000.00
At close:-6000.00 (-4.29%)
Want to see KR:006280 full AI Analyst Report?
GC Biopharma Corp. (006280) Income Statement
GC Biopharma Corp. Income Statement
Last quarter (Q2 2026), GC Biopharma Corp.'s total revenue was ₩421.20B, a decrease of 15.80% from the same quarter last year. In Q2, GC Biopharma Corp.'s net income was ₩1.98B. See GC Biopharma Corp.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 1.99T | ₩ 1.68T | ₩ 1.63T | ₩ 1.71T | ₩ 1.54T | |
| ₩ 536.00B | ₩ 481.93B | ₩ 484.63B | ₩ 581.80B | ₩ 520.59B | |
| ₩ 468.19B | ₩ 449.82B | ₩ 450.20B | ₩ 500.54B | ₩ 446.86B | |
| Depreciation and Amortization | ₩ 87.66B | ₩ 81.03B | ₩ 75.90B | ₩ 65.10B | ₩ 55.90B |
| ₩ 155.46B | ₩ 80.36B | ₩ 109.81B | ₩ 187.32B | ₩ 159.43B | |
| ₩ 67.81B | ₩ 32.11B | ₩ 34.44B | ₩ 81.26B | ₩ 73.66B | |
| ₩ -104.48B | ₩ -73.22B | ₩ -61.57B | ₩ 4.46B | ₩ 98.90B | |
| ₩ -35.33B | ₩ -41.11B | ₩ -27.13B | ₩ 85.73B | ₩ 172.56B | |
| ₩ -4.67B | ₩ -26.28B | ₩ -26.63B | ₩ 65.45B | ₩ 123.21B | |
| Per Share Metrics | |||||
| Basic EPS | ₩ -409.51 | ₩ -2302.62 | ₩ -2333.42 | ₩ 5734.87 | ₩ 10795.00 |
| Diluted EPS | ₩ -409.51 | ₩ -2302.62 | ₩ -2333.42 | ₩ 5734.87 | ₩ 10795.00 |
| Weighted Average Shares Outstanding | 11.41M | 11.41M | 11.41M | 11.41M | 11.41M |
| Weighted Average Shares Outstanding (Diluted) | 11.41M | 11.41M | 11.41M | 11.41M | 11.41M |
Currency in KRW
